Efficacy of second autologous stem cell transplantation in patients with multiple myeloma
Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), S. M. Kulikov(Ministry of Health of the Russian Federation), Maya Soloveva(Ministry of Health of the Russian Federation), M. V. Solovev(Ministry of Health of the Russian Federation), A. A. Startsev(Ministry of Health of the Russian Federation), G. A. Klyasova(Ministry of Health of the Russian Federation), S. E. Starchenko(Ministry of Health of the Russian Federation), Elmira Zalimkhanovna Irugova(Ministry of Health of the Russian Federation)
Cited by 0
Related Papers
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
|Journal of Infection|2017|198
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59